UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of report (date of earliest event reported): September 25, 2007
 
ZIOPHARM Oncology, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
0-32353
 
84-1475642
 
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
1180 Avenue of the Americas, 19th Floor
New York, NY 10036
(Address of principal executive offices) (Zip Code)
 
(646) 214-0700
(Registrant’s telephone number, including area code)

 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01. Other Events.

On September 25, 2007, ZIOPHARM Oncology, Inc. issued the press releases attached hereto as Exhibit 99.1 and Exhibit 99.2, which are incorporated herein by reference.
 
Item 9.01 Financial Statements and Exhibits.
 
(d)     Exhibits.
 
99.1
Press Release dated September 25, 2007.
  99.2 Press Release dated September 25, 2007.
     
 
 
2
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
ZIOPHARM Oncology, Inc.:
(Registrant)
 
 		  
 		  
 
Date: September 26, 2007  By:   /s/ Richard E. Bagley 
 
Richard E. Bagley,
 
President, Chief Operating Officer
and Chief Financial Officer 

3

Exhibit Index

Exhibit No.
Description
   
99.1
Press Release dated September 25, 2007.
    
99.2
Press Release dated September 25, 2007.

4